Willingness to pay for highly active antiretroviral (HAART) drugs and HIV treatment monitoring tests among People Living with HIV/AIDS

Conclusion Majority of people living with HIV/AIDS were willing to pay for antiretrovira l drugs and HIV treatment monitoring tests but only a minor proportion were willing to pay the actual cost of services. This may adversely affect continuity of treatment and enrolment of new patients into the treatment programme. In-order to sustain the gains of the HIV treatment programme and achie ve optimal treatment outcomes for patients on treatment in Nigeria there may be the need to subsidize antiretroviral treatment services for people living with HIV/AIDS.
Source: Australasian Medical Journal - AMJ - Category: General Medicine Source Type: research